APONTIS PHARMA AG |
Market Closed -
Other stock markets
|
After market 12:19:25 am | |||
| 8.5 EUR | -0.47% |
|
8.49 | -0.12% |
| 05/04 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
| 28/03 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Good day, ladies and gentlemen. And on behalf ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Sector
Pharmaceuticals
Calendar
09/08/2024
- Q2 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.54
EUR
Average target price
17.38
EUR
Spread / Average Target
+103.45%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +78.95% | 76.14M | |
| +54.78% | 815B | |
| +44.25% | 654B | |
| -6.19% | 354B | |
| +21.30% | 337B | |
| +11.00% | 302B | |
| +18.45% | 247B | |
| +2.09% | 229B | |
| +13.03% | 219B | |
| +8.79% | 171B |
- Stock Market
- Equities
- APPH Stock
- News Apontis Pharma AG
- Transcript : Apontis Pharma AG, 2023 Earnings Call, Mar 28, 2024
